Pediatric influenza vaccine

A Phase III, Stratified, Randomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to < 72 Months of Age.

Register Today!

Trial Information

Trial Duration13 months
Number of Visits6
Lead CRCMarija Bernstein

For additional information
on this trial contact: